Antarctica currently has few non-native species, compared to other regions of the planet, due to the continent's isolation, extreme climatic conditions and the lack of habitat. However, human activity, particularly the activities of national government operators and tourism, increasingly contributes to the risk of non-native species transfer and establishment. Trichocera (Saltitrichocera) maculipennis Meigen, 1888 (Diptera, Trichoceridae) is a non-native fly originating from the Northern Hemisphere that was unintentionally introduced to King George Island in the maritime Antarctic South Shetland Islands around 15 years ago, since when it has been reported within or in the vicinity of several research stations. It is not explicitly confirmed that T. maculipennis has established in the natural environment, but life-history characteristics make this likely, thereby making potential eradication or control a challenge. Antarctic Treaty Parties active in the region are developing a coordinated and expanding international response to monitor and control T. maculipennis within and around stations in the affected area. However, there remains no overarching non-native invasive species management plan for the island or the wider maritime Antarctic region (which shares similar environmental conditions and habitats to those of King George Island). Here we present some options towards the development of such a plan. We recommend the development of (1) clear mechanisms for the timely coordination of response activities by multiple Parties operating in the vicinity of the introduction location and (2) policy guidance on acceptable levels of environmental impacts resulting from eradication attempts in the natural environment, including the use of pesticides.The thermogenic mechanisms supporting endothermy are still not fully understood in all major mammalian subgroups. In placental mammals, brown adipose tissue currently represents the most accepted source of adaptive non-shivering thermogenesis. Its mitochondrial protein UCP1 (uncoupling protein 1) catalyzes heat production, but the conservation of this mechanism is unclear in non-placental mammals and lost in some placentals. Here, we review the evidence for and against adaptive non-shivering thermogenesis in marsupials, which diverged from placentals about 120-160 million years ago. We critically discuss potential mechanisms that may be involved in the heat-generating process among marsupials.Glioblastoma is the most common and malignant primary brain tumour, with a poor prognosis. Introduction of new treatment options is critically important. The study aimed to assess the appropriateness of escalation doses and toxicity of [225Ac]Ac-DOTA-SP therapy. A total of 21 patients (age of 43.0 ± 9.5years), with histologically confirmed recurrent or conversion glioblastoma grade 4 following a standard therapy, have been included in the study. One to 2 intracavitary port-a-cath systems were stereotactically inserted. Patients were treated with escalation dose protocol with 10, 20 and 30MBq per cycle totally 1-6 doses of [ Ac]Ac-DOTA-SP in 2-month intervals. Therapeutic response was monitored by clinical performance status and MRI imaging. Treatment was well tolerated with mostly mild temporary adverse effects (oedema, epileptic seizures, aphasia, hemiparesis) mainly in the group of patients treated with 30MBq of [ Ac]Ac-DOTA-SP. Only one patient treated with 30MBq revealed thrombopenia grade 3. There was no other grade 3 and 4 toxicity related to [ Ac]Ac-DOTA-treatment in all groups. The median overall survival time from the primary diagnosis (OS-d) was 35.0months and from the diagnosis of the recurrence/conversion (OS-r/c) was 13.2months. From the start of treatment with [ Ac]Ac-DOTA-SP, the median PFS was 2.4months, and the OS-t was 9.0months. There were no statistically significant differences between the investigated dose escalation groups. Treatment of recurrent glioblastoma with [ Ac]Ac-DOTA-SP is safe and well tolerated up to 30MBq per cycle. The escalation dose protocol showed good tolerability. Only mild temporary adverse effects were observed. No remarkable haematological, kidney and liver toxicity was seen. Treatment of recurrent glioblastoma with [225Ac]Ac-DOTA-SP is safe and well tolerated up to 30 MBq per cycle. The escalation dose protocol showed good tolerability. Only mild temporary adverse effects were observed. No remarkable haematological, kidney and liver toxicity was seen. WRKY transcription factors are among the largest families of transcriptional regulators. https://www.selleckchem.com/products/phleomycin-d1.html In this review, their pivotal role in modulating various signal transduction pathways during biotic and abiotic stresses is discussed. Transcription factors (TFs) are important constituents of plant signaling pathways that define plant responses against biotic and abiotic stimuli besides playing a role in response to internal signals which coordinate different interacting partners during developmental processes. WRKY TFs, deriving their nomenclature from their signature DNA-binding sequence, represent one of the largest families of transcriptional regulators found exclusively in plants. By modulating different signal transduction pathways, these TFs contribute to various plant processes including nutrient deprivation, embryogenesis, seed and trichome development, senescence as well as other developmental and hormone-regulated processes. A growing body of research suggests transcriptional regulation of WRKY TFs in adaptigulate diverse biological functions from receptors for pathogen triggered immunity, modulator of chromatin for specific interaction and signal transfer through a complicated network of genes. Latest discoveries illustrate the interaction of WRKY proteins with other TFs to form an integral part of signaling webs that regulate several seemingly disparate processes and defense-related genes, thus establishing their significant contributions to plant immune response. The present review starts with a brief description on the structural characteristics of WRKY TFs followed by the sections that present recent evidence on their roles in diverse biological processes in plants. We provide a comprehensive overview on regulatory crosstalks involving WRKY TFs during multiple stress responses in plants and future prospects of WRKY TFs as promising molecular diagnostics for enhancing crop improvement.